OraSure Technologies | OSUR - Net Income


OraSure Technologies reported $-19.29M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Bruker USD 3.5M 22.5M Mar/2026
Cerus USD -20.92M 17.98M Dec/2024
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -10M 136M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
Illumina USD 134M 200M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Mettler Toledo International USD 169.45M 116.31M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quidel USD -91.8M 38.9M Mar/2026
Repligen USD 8.33M 4.95M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
STAAR Surgical USD 5.21M 23.52M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Trinity Biotech USD -5.14M 11.82M Sep/2025
Waters USD -72M 297.21M Mar/2026